BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36279666)

  • 1. Notoginsenoside R1 induces oxidative stress and modulates LPS induced immune microenvironment of nasopharyngeal carcinoma.
    Li S; Pi G; Zeng Y; Ruan C; He X; Xiong X; Zhang M; Zou J; Liang X
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109323. PubMed ID: 36279666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notoginsenoside R1 alleviates oxidized low-density lipoprotein-induced apoptosis, inflammatory response, and oxidative stress in HUVECS through modulation of XIST/miR-221-3p/TRAF6 axis.
    Zhao J; Cui L; Sun J; Xie Z; Zhang L; Ding Z; Quan X
    Cell Signal; 2020 Dec; 76():109781. PubMed ID: 32947021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notoginsenoside R1 protects WI-38 cells against lipopolysaccharide-triggered injury via adjusting the miR-181a/TLR4 axis.
    Qian D; Shao X; Li Y; Sun X
    J Cell Biochem; 2019 Dec; 120(12):19764-19774. PubMed ID: 31297873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notoginsenoside R1 up-regulates microRNA-132 to protect human lung fibroblast MRC-5 cells from lipopolysaccharide-caused injury.
    Cong S; Xiang L; Yuan X; Bai D; Zhang X
    Int Immunopharmacol; 2019 Mar; 68():137-144. PubMed ID: 30622031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notoginsenoside R1 protects human keratinocytes HaCaT from LPS-induced inflammatory injury by downregulation of Myd88.
    Zhang J; Zheng Q; Lu H; Jin F; Li Y; Bi F; Xu J
    Int J Immunopathol Pharmacol; 2019; 33():2058738419857550. PubMed ID: 31204533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notoginsenoside R1 upregulates miR-221-3p expression to alleviate ox-LDL-induced apoptosis, inflammation, and oxidative stress by inhibiting the TLR4/NF-κB pathway in HUVECs.
    Zhu L; Gong X; Gong J; Xuan Y; Fu T; Ni S; Xu L; Ji N
    Braz J Med Biol Res; 2020; 53(6):e9346. PubMed ID: 32401923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notoginsenoside R1 alleviates high glucose-induced inflammation and oxidative stress in HUVECs via upregulating miR-147a.
    Li XQ; Huang TY
    Kaohsiung J Med Sci; 2021 Dec; 37(12):1101-1112. PubMed ID: 34369659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway.
    Liang Y; Feng G; Wu L; Zhong S; Gao X; Tong Y; Cui W; Qin Y; Xu W; Xiao X; Zhang Z; Huang G; Zhou X
    Drug Des Devel Ther; 2019; 13():1335-1345. PubMed ID: 31118570
    [No Abstract]   [Full Text] [Related]  

  • 9. Simvastatin induces apoptosis of nasopharyngeal carcinoma cells through NF-κB signaling pathway.
    Sun FR; Wang SL; Wang M; Sun LM
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6726-6734. PubMed ID: 32633363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of notoginsenoside R1 on attenuating depressive behavior induced by chronic stress in rats through induction of PI3K/AKT/NF-κB pathway.
    Zhan Q; Wu Y; Liu L
    Drug Dev Res; 2022 Feb; 83(1):97-104. PubMed ID: 34173680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notoginsenoside R1 Protects HUVEC Against Oxidized Low Density Lipoprotein (Ox-LDL)-Induced Atherogenic Response via Down-Regulating miR-132.
    Fu C; Yin D; Nie H; Sun D
    Cell Physiol Biochem; 2018; 51(4):1739-1750. PubMed ID: 30504696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lupeol triggers oxidative stress, ferroptosis, apoptosis and restrains inflammation in nasopharyngeal carcinoma via AMPK/NF-κB pathway.
    Zhou JC; Wu B; Zhang JJ; Zhang W
    Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):621-631. PubMed ID: 35486494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notoginsenoside R1 ameliorates the inflammation induced by amyloid‑β by suppressing SphK1‑mediated NF‑κB activation in PC12 cells.
    Wang X; Li B; Yu X; Zhou Y; Wang K; Gao Y
    Mol Med Rep; 2024 Jan; 29(1):. PubMed ID: 38063180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notoginsenoside R1 Ameliorates Diabetic Retinopathy through PINK1-Dependent Activation of Mitophagy.
    Zhou P; Xie W; Meng X; Zhai Y; Dong X; Zhang X; Sun G; Sun X
    Cells; 2019 Mar; 8(3):. PubMed ID: 30832367
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of NADPH oxidase- and mitochondrion-derived superoxide by Notoginsenoside R1 protects against cerebral ischemia-reperfusion injury through estrogen receptor-dependent activation of Akt/Nrf2 pathways.
    Meng X; Wang M; Wang X; Sun G; Ye J; Xu H; Sun X
    Free Radic Res; 2014 Jul; 48(7):823-38. PubMed ID: 24720662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notoginsenoside R1 attenuates oxidative stress-induced osteoblast dysfunction through JNK signalling pathway.
    Li X; Lin H; Zhang X; Jaspers RT; Yu Q; Ji Y; Forouzanfar T; Wang D; Huang S; Wu G
    J Cell Mol Med; 2021 Dec; 25(24):11278-11289. PubMed ID: 34786818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0114427 promotes LPS-induced septic acute kidney injury by modulating miR-495-3p/TRAF6 through the NF-κB pathway.
    Xu L; Cao H; Xu P; Nie M; Zhao C
    Autoimmunity; 2022 Feb; 55(1):52-64. PubMed ID: 34730059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human colorectal cancer metastasis by notoginsenoside R1, an important compound from Panax notoginseng.
    Lee CY; Hsieh SL; Hsieh S; Tsai CC; Hsieh LC; Kuo YH; Wu CC
    Oncol Rep; 2017 Jan; 37(1):399-407. PubMed ID: 27840961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydromyricetin promotes apoptosis, suppresses proliferation and tumor necrosis factor-α-mediated nuclear factor kappa-B activation in nasopharyngeal carcinoma CNE-2 cell.
    Li CH; Ding H; Shi JL; Huang B; Ding H; Lin HG; Zeng JC; Zhao Y; Luo GQ
    J Tradit Chin Med; 2021 Jun; 41(3):367-375. PubMed ID: 34114393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
    Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ
    Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.